loading
Reshape Lifesciences Inc stock is traded at $2.48, with a volume of 532.15K. It is down -9.16% in the last 24 hours and up +0.81% over the past month. Reshape Lifesciences Inc is a medical device company focused on technologies to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, ReShapeCare virtual health coaching program, ReShape Market Place, including ReShape Optimize a supplemental multivitamin, the Obalon Balloon System, the first and only swallowable gas-filled balloon system, and the Diabetes Bloc-Stim Neuromodulation, a technology under development as a new treatment for type 2 diabetes mellitus. Geographically, the company operates in the United States, Australia, Europe, and the Rest of world, and the majority of its revenue is generated from the United States.
See More
Previous Close:
$2.73
Open:
$2.59
24h Volume:
532.15K
Relative Volume:
0.22
Market Cap:
$3.30M
Revenue:
$9.81M
Net Income/Loss:
$-26.16M
P/E Ratio:
-0.064
EPS:
-38.77
Net Cash Flow:
$-17.45M
1W Performance:
-22.01%
1M Performance:
+0.81%
6M Performance:
-97.77%
1Y Performance:
-99.19%
1-Day Range:
Value
$2.45
$2.73
1-Week Range:
Value
$2.45
$3.49
52-Week Range:
Value
$2.23
$312.04

Reshape Lifesciences Inc Stock (RSLS) Company Profile

Name
Name
Reshape Lifesciences Inc
Name
Phone
949-429-6680
Name
Address
1001 CALLE AMANECER, SAN CLEMENTE
Name
Employee
18
Name
Twitter
Name
Next Earnings Date
2024-11-06
Name
Latest SEC Filings
Name
RSLS's Discussions on Twitter

Compare RSLS with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Medical Devices icon
RSLS
Reshape Lifesciences Inc
2.48 6.51M 9.81M -26.16M -17.45M -38.77
Medical Devices icon
ABT
Abbott Laboratories
126.54 218.59B 43.11B 13.98B 6.66B 7.98
Medical Devices icon
BSX
Boston Scientific Corp
106.14 157.13B 18.49B 2.51B 2.72B 1.68
Medical Devices icon
SYK
Stryker Corp
403.53 151.59B 23.22B 2.86B 3.58B 7.40
Medical Devices icon
MDT
Medtronic Plc
92.94 118.29B 33.54B 4.66B 5.19B 3.62
Medical Devices icon
EW
Edwards Lifesciences Corp
80.00 44.46B 5.54B 4.18B 623.10M 7.00

Reshape Lifesciences Inc Stock (RSLS) Latest News

pulisher
Jul 25, 2025

ReShape Lifesciences Holds Special Stockholder Meeting - TipRanks

Jul 25, 2025
pulisher
Jul 25, 2025

What drives ReShape Lifesciences Inc. stock priceTremendous growth potential - PrintWeekIndia

Jul 25, 2025
pulisher
Jul 25, 2025

What analysts say about ReShape Lifesciences Inc. stockPhenomenal capital appreciation - Autocar Professional

Jul 25, 2025
pulisher
Jul 25, 2025

Will ReShape Lifesciences Inc. stock split in the near futureOverwhelming profit margins - jammulinksnews.com

Jul 25, 2025
pulisher
Jul 24, 2025

ReShape Lifesciences Announces Partial Adjournment of Stockholder Meeting for Asset Sale and Charter Amendment Proposals - Nasdaq

Jul 24, 2025
pulisher
Jul 24, 2025

ReShape Lifesciences® Announces Partial Adjournment of Special Meeting of Stockholders - GlobeNewswire

Jul 24, 2025
pulisher
Jul 24, 2025

ReShape Lifesciences Merger at Critical Stage: Stockholders Must Approve Asset Sale by August 7 - Stock Titan

Jul 24, 2025
pulisher
Jul 24, 2025

Is RSLS a good stock - AInvest

Jul 24, 2025
pulisher
Jul 23, 2025

Is ReShape Lifesciences Inc. a good long term investmentHigh-profit stock alerts - jammulinksnews.com

Jul 23, 2025
pulisher
Jul 23, 2025

ReShape Lifesciences Inc. Stock Analysis and ForecastTriple-digit profit margins - Autocar Professional

Jul 23, 2025
pulisher
Jul 22, 2025

ReShape's New Lap-Band 2.0 FLEX Targets GLP-1 Era: Top Surgeons Gather for Groundbreaking Summit - Stock Titan

Jul 22, 2025
pulisher
Jul 22, 2025

ReShape Lifesciences® to Host Inaugural Lap-Band® Surgeon Summit - GlobeNewswire

Jul 22, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences Hosts Special Meeting of Stockholders on July 24, 2025 - AInvest

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences Board Unanimously Recommends Merger with Vyome Therapeutics and Sale of Assets to Biorad Medisys - Nasdaq

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences® Receives Notice of Allowance for Key U.S. Patent Related to an Intragastric Balloon System - Yahoo.co

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - GlobeNewswire

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences® to Host Special Meeting of Stockholders on July 24, 2025 - Benzinga

Jul 21, 2025
pulisher
Jul 21, 2025

ReShape Lifesciences Strategic Transformation: Board and Proxy Advisors Unite Behind Vyome Merger - Stock Titan

Jul 21, 2025
pulisher
Jul 18, 2025

How high can ReShape Lifesciences Inc. stock price go in 2025Free Access to Community - Newser

Jul 18, 2025
pulisher
Jul 16, 2025

ReShape Lifesciences Announces Merger with Vyome Therapeutics - The Globe and Mail

Jul 16, 2025
pulisher
Jul 16, 2025

Why ReShape Lifesciences Inc. stock attracts strong analyst attentionFree Stock Selection with 300% Return - Newser

Jul 16, 2025
pulisher
Jul 15, 2025

What makes ReShape Lifesciences Inc. stock price move sharplyFree Join Group - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How ReShape Lifesciences Inc. stock performs during market volatilityFree Capital Growth Strategies - Newser

Jul 15, 2025
pulisher
Jul 05, 2025

ReShape Lifesciences announces 1-for-25 reverse stock split By Investing.com - Investing.com Nigeria

Jul 05, 2025
pulisher
Jul 03, 2025

ReShape Lifesciences Loans $200K to Vyome Therapeutics - TipRanks

Jul 03, 2025
pulisher
Jul 01, 2025

ReShape Lifesciences to receive patent for swallowable balloon device - Investing.com

Jul 01, 2025
pulisher
Jul 01, 2025

ReShape Lifesciences® Granted U.S. Patent Related to an Intragastric Balloon System - The Manila Times

Jul 01, 2025
pulisher
Jul 01, 2025

Game-Changing Patent: ReShape's New Self-Degrading Weight Loss Balloon Could Transform Obesity Treatment - Stock Titan

Jul 01, 2025
pulisher
Jun 29, 2025

RSLS 425及美國證券交易委員會申報文件 - Yahoo 財經

Jun 29, 2025
pulisher
Jun 28, 2025

ReShape Lifesciences: Navigating Regulatory Recovery – Is This Turnaround Sustainable? - AInvest

Jun 28, 2025

Reshape Lifesciences Inc Stock (RSLS) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$290.22
price up icon 1.27%
medical_devices STE
$230.46
price up icon 1.41%
medical_devices PHG
$26.16
price up icon 1.24%
$88.99
price up icon 2.59%
$77.61
price up icon 1.09%
medical_devices EW
$80.00
price up icon 5.54%
Cap:     |  Volume (24h):